Wysenski Nancy

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$557,421.66
Insider Sells Quantity
7
Insider Sells Sum
$23.65M

Insider Activity of Wysenski Nancy

The largest purchase of all time was on 2020-02-24 and amounted to 13880 shares of Alkermes plc for $272,742.

The largest sale of all time was on 2012-05-14 and amounted to 180000 shares of Vertex Pharmaceuticals Incorporated for $11.57M.

Biography of Wysenski Nancy

No biography is available at this moment.

2023-05-09SaleAlkermes plc
ALKS
director
41,250
0.0252%
$31.24$1.29M-9.28%
2020-02-24PurchaseAlkermes plc
ALKS
director
13,880
0.0087%
$19.65$272,742-9.66%
2019-03-14PurchaseAlkermes plc
ALKS
director
890
0.0006%
$33.06$29,423-36.21%
2019-02-21PurchaseAlkermes plc
ALKS
director
7,714
0.005%
$33.09$255,256-33.96%
2012-05-14SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Commercial Officer
180,000
0.0846%
$64.27$11.57M-18.47%
2012-05-08SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Commercial Officer
38,009
0.0174%
$62.10$2.36M-17.78%
2012-05-07SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Commercial Officer
147,695
0.0655%
$54.50$8.05M-9.24%
2012-01-19SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Commercial Officer
6,042
0.0029%
$37.00$223,554+30.51%
2011-12-12SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Commercial Officer
5,000
0.0024%
$28.90$144,500+57.24%
2011-11-15SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Commercial Officer
606
0.0003%
$29.77$18,041+55.39%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.